| Literature DB >> 28704437 |
Peggy S Lai1,2,3, Joseph G Allen2, Diane S Hutchinson4, Nadim J Ajami4, Joseph F Petrosino4, Thomas Winters2, Christopher Hug5, Gary R Wartenberg3, Jose Vallarino2, David C Christiani1,2,3.
Abstract
OBJECTIVES: To characterize the microbial environment of workers in academic mouse research facilities using endotoxin, 16S qPCR, and 16S amplicon sequencing. To determine whether the work microbiome contributes to the human microbiome of workers.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28704437 PMCID: PMC5509249 DOI: 10.1371/journal.pone.0180969
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary measures of endotoxin, mouse allergen, and 16S rDNA copies per cubic meter of air sampled by location (animal, dirty, middle, set up locations).
Values depicted are median [interquartile range]. Average endotoxin levels were low and not statistically different between locations, although measures of total bacterial count with quantitative PCR of 16S rDNA showed significant differences in bacterial counts between locations, with the highest counts in the dirty location. Spearman correlation between endotoxin and 16S rDNA copies was 0.62. Mouse allergen levels were also significantly different across location.
| Measure | Location | p-value | |||
|---|---|---|---|---|---|
| Animal Room | Dirty (Area) | Middle | Set Up | ||
| Endotoxin, EU/m3 | 0 | 1.0 | 0.7 | 0.5 | 0.28 |
| 16S rDNA, copies/m3 | 2,598.7 | 28,396.0 | 4,256.1 | 4,031.2 | <0.001 |
| Mouse allergen, ng/m3 | 1.2 | 5.6 | 0.3 | 0.3 | 0.01 |
| Observations | 4 | 4 | 4 | 4 | |
Characteristics of study participants.
| Characteristic | Mean ± SD or N (%) |
|---|---|
| Participants | 10 |
| Age (years) | 46.5 ± 11.9 |
| Men | 10 (100%) |
| Body mass index (kg/m2) | 29.5 ± 7.6 |
| Years worked | 10.4 ± 2.2 |
| Doctor diagnosis of asthma | 3 (30%) |
| Doctor diagnosis of hayfever | 5 (50%) |
| Lifetime nonsmoker | 3 (30%) |
| Current smoker | 4 (40%) |
| Pack-years | 11.3 ± 3.6 |
| FEV1 (liters) | 2.8 |
| % predicted FEV1 | 87.0 ± 15.3 |
| FVC (liters) | 3.6 |
| % predicted FVC | 85.6 ± 17.6 |
| FEV1/FVC < 0.70 | 2 (20%) |
| + Bronchodilator response | 2 (20%) |
| Exhaled nitric oxide (ppb) | 19.4 ± 14.6 |
| Work-related symptoms | 3 (30%) |
| Cross-shift change in FEV1 (mL) | 40 ± 179.7 |
| Cross-shift change in exhaled nitric oxide (ppb) | 2.8 ± 5.3 |
a Two subjects had pre- or post-shift spirometry that did not meet ATS criteria for reproducibility and so were excluded from the analysis